Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
Structure Therapeutics (NASDAQ: GPCR), a clinical-stage biopharmaceutical company focused on developing oral small molecule therapeutics for metabolic diseases, has announced its participation in two major healthcare investor conferences in June 2025:
- The Jefferies Global Healthcare Conference on June 5 at 8:10 a.m. ET in New York, featuring a fireside chat and one-on-one meetings
- The Goldman Sachs Global Healthcare Conference on June 11 at 10:40 a.m. ET in Miami, also including a fireside chat and one-on-one meetings
Both fireside chat sessions will be available via webcast on the company's investor relations website, with replays accessible for 90 days.
Structure Therapeutics (NASDAQ: GPCR), una società biofarmaceutica in fase clinica specializzata nello sviluppo di terapie orali a piccola molecola per malattie metaboliche, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel settore sanitario a giugno 2025:
- La Jefferies Global Healthcare Conference il 5 giugno alle 8:10 ET a New York, che includerà una discussione informale e incontri individuali
- La Goldman Sachs Global Healthcare Conference l'11 giugno alle 10:40 ET a Miami, con una discussione informale e incontri individuali
Entrambe le sessioni di discussione informale saranno disponibili in webcast sul sito web delle relazioni con gli investitori della società, con repliche accessibili per 90 giorni.
Structure Therapeutics (NASDAQ: GPCR), una compañía biofarmacéutica en fase clínica centrada en el desarrollo de terapias orales de pequeñas moléculas para enfermedades metabólicas, ha anunciado su participación en dos importantes conferencias para inversores del sector salud en junio de 2025:
- La Jefferies Global Healthcare Conference el 5 de junio a las 8:10 a.m. ET en Nueva York, que incluirá una charla informal y reuniones uno a uno
- La Goldman Sachs Global Healthcare Conference el 11 de junio a las 10:40 a.m. ET en Miami, también con charla informal y reuniones uno a uno
Ambas sesiones de charla informal estarán disponibles vía webcast en el sitio web de relaciones con inversores de la compañía, con repeticiones accesibles durante 90 días.
Structure Therapeutics(나스닥: GPCR)는 대사 질환을 위한 경구용 소분자 치료제 개발에 집중하는 임상 단계 바이오제약 회사로, 2025년 6월에 개최되는 두 주요 헬스케어 투자자 컨퍼런스에 참여한다고 발표했습니다:
- 6월 5일 뉴욕에서 오전 8시 10분(동부시간)에 열리는 Jefferies Global Healthcare Conference로, 파이어사이드 채팅과 일대일 미팅이 포함됩니다
- 6월 11일 마이애미에서 오전 10시 40분(동부시간)에 열리는 Goldman Sachs Global Healthcare Conference로, 역시 파이어사이드 채팅과 일대일 미팅이 포함됩니다
두 파이어사이드 채팅 세션 모두 회사 투자자 관계 웹사이트를 통해 웹캐스트로 제공되며, 재방송은 90일간 시청 가능합니다.
Structure Therapeutics (NASDAQ : GPCR), une société biopharmaceutique en phase clinique spécialisée dans le développement de petites molécules orales pour les maladies métaboliques, a annoncé sa participation à deux grandes conférences pour investisseurs dans le secteur de la santé en juin 2025 :
- La Jefferies Global Healthcare Conference le 5 juin à 8h10 ET à New York, comprenant une discussion informelle et des rencontres individuelles
- La Goldman Sachs Global Healthcare Conference le 11 juin à 10h40 ET à Miami, incluant également une discussion informelle et des rencontres individuelles
Les deux sessions de discussion informelle seront disponibles en webcast sur le site des relations investisseurs de la société, avec des rediffusions accessibles pendant 90 jours.
Structure Therapeutics (NASDAQ: GPCR), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf die Entwicklung oraler Kleinmolekültherapeutika für Stoffwechselerkrankungen spezialisiert hat, hat seine Teilnahme an zwei wichtigen Gesundheitsinvestorenkonferenzen im Juni 2025 angekündigt:
- Die Jefferies Global Healthcare Conference am 5. Juni um 8:10 Uhr ET in New York, mit einem Fireside-Chat und Einzelgesprächen
- Die Goldman Sachs Global Healthcare Conference am 11. Juni um 10:40 Uhr ET in Miami, ebenfalls mit Fireside-Chat und Einzelgesprächen
Beide Fireside-Chat-Sitzungen werden per Webcast auf der Investor-Relations-Website des Unternehmens verfügbar sein, mit Wiederholungen, die 90 Tage lang abrufbar sind.
- None.
- None.
SAN FRANCISCO, May 29, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced that management will participate in multiple upcoming healthcare conferences in June.
Jefferies Global Healthcare Conference
Format: Fireside chat and 1x1 meetings
Date/time: Thursday, June 5 at 8:10 a.m. ET
Location: New York, NY
Goldman Sachs Global Healthcare Conference
Format: Fireside chat and 1x1 meetings
Date/time: Wednesday, June 11 at 10:40 a.m. ET
Location: Miami, FL
The live and archived webcasts of the fireside chats will be accessible from the company’s website at https://ir.structuretx.com/events-presentations/events and a replay will be available for 90 days.
About Structure Therapeutics
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, Structure Therapeutics has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world. For additional information, please visit www.structuretx.com.
Investors:
Danielle Keatley
Structure Therapeutics Inc.
ir@structuretx.com
Media:
Dan Budwick
1AB
Dan@1abmedia.com
FAQ
What investor conferences will Structure Therapeutics (GPCR) attend in June 2025?
When is Structure Therapeutics' (GPCR) presentation at the Jefferies Healthcare Conference?
How can investors access Structure Therapeutics' (GPCR) conference presentations?
What type of company is Structure Therapeutics (GPCR)?
